HEADER HYDROLASE 06-FEB-02 1GV7 TITLE ARH-I, AN ANGIOGENIN/RNASE A CHIMERA COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOGENIN; COMPND 3 CHAIN: A; COMPND 4 EC: 3.1.27.5; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, BOS TAURUS; SOURCE 3 ORGANISM_COMMON: HUMAN, BOVINE; SOURCE 4 ORGANISM_TAXID: 9606, 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 316407; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: W3110; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PANG3; SOURCE 9 OTHER_DETAILS: SUBSTITUTED SEQUENCE IS BOVINE. SYNTHETIC GENE KEYWDS HYDROLASE, PANCREATIC RIBONUCLEASE, ANGIOGENESIS, ANGIOGENIN, KEYWDS 2 CHIMERA, HYBRID, HOMOLOG SCANNING MUTAGENESIS EXPDTA X-RAY DIFFRACTION AUTHOR D.E.HOLLOWAY,R.SHAPIRO,M.C.HARES,D.D.LEONIDAS,K.R.ACHARYA REVDAT 7 13-DEC-23 1GV7 1 REMARK REVDAT 6 11-MAR-20 1GV7 1 SEQRES REVDAT 5 13-MAR-19 1GV7 1 JRNL REMARK REVDAT 4 06-MAR-19 1GV7 1 REMARK LINK REVDAT 3 15-MAR-17 1GV7 1 SOURCE REVDAT 2 24-FEB-09 1GV7 1 VERSN REVDAT 1 22-AUG-02 1GV7 0 JRNL AUTH D.E.HOLLOWAY,R.SHAPIRO,M.C.HARES,D.D.LEONIDAS,K.R.ACHARYA JRNL TITL GUEST-HOST CROSSTALK IN AN ANGIOGENIN-RNASE A CHIMERIC JRNL TITL 2 PROTEIN JRNL REF BIOCHEMISTRY V. 41 10482 2002 JRNL REFN ISSN 0006-2960 JRNL PMID 12173935 JRNL DOI 10.1021/BI026151R REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 837742.300 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.1 REMARK 3 NUMBER OF REFLECTIONS : 8425 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.600 REMARK 3 FREE R VALUE TEST SET COUNT : 894 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1251 REMARK 3 BIN R VALUE (WORKING SET) : 0.3250 REMARK 3 BIN FREE R VALUE : 0.3760 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 125 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.034 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 947 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 13 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.39 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.860 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.420 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.420 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.860 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.900 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 54.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : LPYGLU_PROSTHETIC.PARAM REMARK 3 PARAMETER FILE 4 : CITRATE_O_70.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : LPYGLU_PROSTHETIC.TOP REMARK 3 TOPOLOGY FILE 4 : CITRATE_O_70.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GV7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-FEB-02. REMARK 100 THE DEPOSITION ID IS D_1290009416. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-00 REMARK 200 TEMPERATURE (KELVIN) : 292.0 REMARK 200 PH : 5.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.244 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8426 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.10800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.58400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1B1I REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOUR DIFFUSION, 16 C 10 MG/ML REMARK 280 PROTEIN, 15 % PEG 4000, 8 % TERT-BUTANOL, 0.3 M AMMONIUM ACETATE, REMARK 280 0.1 M SODIUM CITRATE BUFFER, PH 5.8, PH 5.80, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 19.27350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.09950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.27350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.09950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2002 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2006 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 SUBSTITUTION OF ANGIOGENIN RESIDUES 58-70 WITH REMARK 400 RNASE A RESIDUES 85-97 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 24 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 31 CG CD NE CZ NH1 NH2 REMARK 470 SER A 37 OG REMARK 470 ARG A 51 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 65 CG CD CE NZ REMARK 470 ARG A 123 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 21 34.71 -155.61 REMARK 500 GLN A 59 -156.90 -113.96 REMARK 500 ASN A 70 44.03 -96.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A3001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A4Y RELATED DB: PDB REMARK 900 RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX REMARK 900 RELATED ID: 1ANG RELATED DB: PDB REMARK 900 ANGIOGENIN REMARK 900 RELATED ID: 1AWZ RELATED DB: PDB REMARK 900 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR REMARK 900 SPECTROSCOPY, 30 STRUCTURES REMARK 900 RELATED ID: 1B1E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Q REMARK 900 RELATED ID: 1B1I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REMARK 900 RELATED ID: 1B1J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A. REMARK 900 RELATED ID: 1H52 RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF REMARK 900 HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1H53 RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF REMARK 900 HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1HBY RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF REMARK 900 HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 2ANG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORM REMARK 999 REMARK 999 SEQUENCE REMARK 999 CHIMERA, DESCRIBED IN HARPER ET AL (1988) PNAS 85, 7139-43 DBREF 1GV7 A 1 57 UNP P03950 ANGI_HUMAN 25 81 DBREF 1GV7 A 58 70 UNP P00656 RNP_BOVIN 85 97 DBREF 1GV7 A 71 123 UNP P03950 ANGI_HUMAN 95 147 SEQRES 1 A 123 PCA ASP ASN SER ARG TYR THR HIS PHE LEU THR GLN HIS SEQRES 2 A 123 TYR ASP ALA LYS PRO GLN GLY ARG ASP ASP ARG TYR CYS SEQRES 3 A 123 GLU SER ILE MET ARG ARG ARG GLY LEU THR SER PRO CYS SEQRES 4 A 123 LYS ASP ILE ASN THR PHE ILE HIS GLY ASN LYS ARG SER SEQRES 5 A 123 ILE LYS ALA ILE CYS SER GLN LYS ASN VAL ALA CYS LYS SEQRES 6 A 123 ASN GLY GLN THR ASN CYS TYR ILE SER LYS SER SER PHE SEQRES 7 A 123 GLN VAL THR THR CYS LYS LEU HIS GLY GLY SER PRO TRP SEQRES 8 A 123 PRO PRO CYS GLN TYR ARG ALA THR ALA GLY PHE ARG ASN SEQRES 9 A 123 VAL VAL VAL ALA CYS GLU ASN GLY LEU PRO VAL HIS LEU SEQRES 10 A 123 ASP GLN SER ILE PHE ARG MODRES 1GV7 PCA A 1 GLU PYROGLUTAMIC ACID HET PCA A 1 8 HET CIT A3001 13 HETNAM PCA PYROGLUTAMIC ACID HETNAM CIT CITRIC ACID FORMUL 1 PCA C5 H7 N O3 FORMUL 2 CIT C6 H8 O7 FORMUL 3 HOH *62(H2 O) HELIX 1 1 ASN A 3 TYR A 14 1 12 HELIX 2 2 ASP A 22 ARG A 33 1 12 HELIX 3 3 ASN A 49 ALA A 55 1 7 HELIX 4 4 ILE A 56 GLN A 59 5 4 HELIX 5 5 GLN A 119 ARG A 123 5 5 SHEET 1 AA 3 ILE A 42 ILE A 46 0 SHEET 2 AA 3 PHE A 78 LEU A 85 -1 O THR A 81 N PHE A 45 SHEET 3 AA 3 TYR A 96 ARG A 103 -1 O ARG A 97 N LYS A 84 SHEET 1 AB 4 ASN A 61 VAL A 62 0 SHEET 2 AB 4 CYS A 71 ILE A 73 -1 O CYS A 71 N VAL A 62 SHEET 3 AB 4 VAL A 106 GLU A 110 -1 O VAL A 107 N TYR A 72 SHEET 4 AB 4 LEU A 113 LEU A 117 -1 O LEU A 113 N GLU A 110 SSBOND 1 CYS A 26 CYS A 83 1555 1555 2.04 SSBOND 2 CYS A 39 CYS A 94 1555 1555 2.03 SSBOND 3 CYS A 57 CYS A 109 1555 1555 2.03 SSBOND 4 CYS A 64 CYS A 71 1555 1555 2.03 LINK C PCA A 1 N ASP A 2 1555 1555 1.33 CISPEP 1 SER A 37 PRO A 38 0 0.12 CISPEP 2 PRO A 92 PRO A 93 0 0.30 SITE 1 AC1 9 HIS A 8 GLN A 12 HIS A 13 LYS A 40 SITE 2 AC1 9 HIS A 116 LEU A 117 GLN A 119 HOH A2061 SITE 3 AC1 9 HOH A2062 CRYST1 38.547 64.199 61.250 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025942 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015576 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016326 0.00000 HETATM 1 N PCA A 1 19.683 35.413 17.631 1.00 44.77 N HETATM 2 CA PCA A 1 18.346 35.337 18.175 1.00 44.99 C HETATM 3 CB PCA A 1 17.934 36.799 18.302 1.00 44.37 C HETATM 4 CG PCA A 1 18.758 37.475 17.202 1.00 44.86 C HETATM 5 CD PCA A 1 19.967 36.600 17.068 1.00 45.05 C HETATM 6 OE PCA A 1 21.058 36.876 16.543 1.00 44.32 O HETATM 7 C PCA A 1 17.407 34.494 17.309 1.00 43.80 C HETATM 8 O PCA A 1 16.194 34.401 17.735 1.00 45.69 O